Pay in 4 interest-free payments of $5.79 Learn more
Ships within 48 hours · Estimated delivery Aug 21 - Aug 26
This figure is directly comparable to the performance of tirzepatide (Mounjaro) in the SURMOUNT-1 trial, which showed approximately 20.9% weight loss at 72 weeks, and exceeds the approximately 14.9% achieved by semaglutide alone in STEP 1
Injections may incur higher costs due to clinic visits and professional administration
Kurume Med J (2000) 47(3):199203
A: GLP-1s may be covered for approved indications (criteria vary by plan)
doi: 10.1126/sciadv.abk1131 295 SarasteM.BezukladovaS.MatilainenM.SucksdorffM.KuhleJ.LeppertD.et al
Utilizing Developmentally Essential Secreted Peptides Such as thymosin Beta-4 to Remind the Adult Organs of Their Embryonic State New Directions in Anti-Aging Regenerative Therapies
US$ 21.84
US$ 28.63
US$ 26.64
